Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ITGAV | P06756 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14727684 | 0.86 | KMT2A (0.38) | GPR119MEN1KMT2A | |
| SCHEMBL14727703 | 0.84 | GPR119 (0.36) | GPR119KMT2A | |
| SCHEMBL14727675 | 0.84 | KMT2A (0.39) | GPR119MEN1KMT2A | |
| SCHEMBL14727698 | 0.81 | THRB (0.35) | GPR119ITGB3ITGA2BMEN1KMT2A | |
| SCHEMBL14727682 | 0.81 | KMT2A (0.36) | GPR119KMT2A | |
| SCHEMBL14727705 | 0.81 | ELANE (0.38) | GPR119MEN1KMT2A | |
| SCHEMBL14727683 | 0.81 | THRB (0.44) | GPR119MEN1KMT2A | |
| SCHEMBL14478762 | 0.80 | KMT2A (0.36) | GPR119MEN1KMT2A | |
| SCHEMBL14727710 | 0.79 | POLB (0.46) | GPR119MEN1KMT2APOLBAPEX1 | |
| SCHEMBL14727681 | 0.79 | KMT2A (0.40) | GPR119MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8840807-B2 | Polymerizable compound | JNC CORPORATION (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20130048912-A1 | POLYMERIZABLE COMPOUND | JNC PETROCHEMICAL CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048912-A1 | POLYMERIZABLE COMPOUND | PYM1, ZYX, CPNE4 | GPR119 4098/4885ITGB3 2797/4885ITGA2B 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.